118 related articles for article (PubMed ID: 10517447)
41. Ovarian surface epithelial neoplasms in the pediatric population: incidence, histologic subtype, and natural history.
Hazard FK; Longacre TA
Am J Surg Pathol; 2013 Apr; 37(4):548-53. PubMed ID: 23388124
[TBL] [Abstract][Full Text] [Related]
42. [Pathology of ovarian cancer].
Kaku T; Watanabe S; Ohishi Y
Nihon Rinsho; 2012 Jun; 70 Suppl 4():512-6. PubMed ID: 23156300
[No Abstract] [Full Text] [Related]
43. Second-look laparotomy after modified posterior exenteration: patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer.
Spirtos NM; Eisenkop SM; Schlaerth JB; Ballon SC
Am J Obstet Gynecol; 2000 Jun; 182(6):1321-7. PubMed ID: 10871445
[TBL] [Abstract][Full Text] [Related]
44. Advances in the management of epithelial ovarian cancer.
Berkenblit A; Cannistra SA
J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
[TBL] [Abstract][Full Text] [Related]
45. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
46. Serous carcinoma of the ovary: CT identification of metastatic calcified implants.
Mitchell DG; Hill MC; Hill S; Zaloudek C
Radiology; 1986 Mar; 158(3):649-52. PubMed ID: 3945732
[TBL] [Abstract][Full Text] [Related]
47. Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates.
Gurung A; Hung T; Morin J; Gilks CB
Histopathology; 2013 Jan; 62(1):59-70. PubMed ID: 23240670
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical localization of HE4 in benign, borderline, and malignant lesions of the ovary.
Georgakopoulos P; Mehmood S; Akalin A; Shroyer KR
Int J Gynecol Pathol; 2012 Nov; 31(6):517-23. PubMed ID: 23018214
[TBL] [Abstract][Full Text] [Related]
49. Ovarian serous borderline tumors with invasive peritoneal implants.
Gershenson DM; Silva EG; Levy L; Burke TW; Wolf JK; Tornos C
Cancer; 1998 Mar; 82(6):1096-103. PubMed ID: 9506355
[TBL] [Abstract][Full Text] [Related]
50. Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor.
Kodama J; Hashimoto I; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T
Anticancer Res; 2001; 21(4B):2983-7. PubMed ID: 11712798
[TBL] [Abstract][Full Text] [Related]
51. Ovarian cancer is a heterogeneous disease.
Wang V; Li C; Lin M; Welch W; Bell D; Wong YF; Berkowitz R; Mok SC; Bandera CA
Cancer Genet Cytogenet; 2005 Sep; 161(2):170-3. PubMed ID: 16102589
[TBL] [Abstract][Full Text] [Related]
52. Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI.
Forstner R
Eur Radiol; 2007 Dec; 17(12):3223-35. PubMed ID: 17701180
[TBL] [Abstract][Full Text] [Related]
53. Ultrasound, macroscopic and histological features of endometrioid and clear cell ovarian cancer.
Bolomini G; Bertoldo V; Zannoni GF; Pozzati F
Int J Gynecol Cancer; 2021 Jun; 31(6):938-939. PubMed ID: 33139316
[No Abstract] [Full Text] [Related]
54. Computed tomography findings of ovarian metastases from colon cancer: comparison with primary malignant ovarian tumors.
Choi HJ; Lee JH; Seo SS; Lee S; Kim SK; Kim JY; Lee JS; Park SY; Kim YH
J Comput Assist Tomogr; 2005; 29(1):69-73. PubMed ID: 15665686
[TBL] [Abstract][Full Text] [Related]
55. Use of the computed tomographic whole body scanner to stage and follow patients with advanced ovarian carcinoma.
Whitley N; Brenner D; Francis A; Kwon T; Villasanta U; Aisner J; Wiernik P; Whitley J
Invest Radiol; 1981; 16(6):479-86. PubMed ID: 7319753
[TBL] [Abstract][Full Text] [Related]
56. Variable CT findings of epithelial origin ovarian carcinoma according to the degree of histologic differentiation.
Jang YJ; Kim JK; Park SB; Cho KS
Korean J Radiol; 2007; 8(2):120-6. PubMed ID: 17420629
[TBL] [Abstract][Full Text] [Related]
57. CT in ovarian cancer staging: how to review and report with emphasis on abdominal and pelvic disease for surgical planning.
Sahdev A
Cancer Imaging; 2016 Aug; 16(1):19. PubMed ID: 27484100
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of preoperative prediction of intestinal invasion in patients with ovarian cancer.
Takeda T; Hayashi S; Kobayashi Y; Tsuji K; Nagai S; Tominaga E; Suzuki T; Okuda S; Banno K; Aoki D
Int J Gynaecol Obstet; 2021 Jun; 153(3):398-404. PubMed ID: 33222157
[TBL] [Abstract][Full Text] [Related]
59. CT and MRI of ovarian cancer.
Forstner R; Hricak H; White S
Abdom Imaging; 1995; 20(1):2-8. PubMed ID: 7894290
[TBL] [Abstract][Full Text] [Related]
60. Computed tomography in the evaluation of carcinoma of the ovary.
Amendola MA; Walsh JW; Amendola BE; Tisnado J; Hall DJ; Goplerud DR
J Comput Assist Tomogr; 1981 Apr; 5(2):179-86. PubMed ID: 7217442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
